Advertisement

Preliminary Remarks

  • Volker Eric Amelung
Chapter
Part of the Springer Texts in Business and Economics book series (STBE)

Abstract

“After a turbulent decade of trial and error, that experiment can be characterized as an economic success but a political failure”, stated Robinson (2001, p. 2622), for the United States some years ago. In particular, the question was raised of whether MCOs used “managed care” or “managed costs”. Critics emphasise that MCOs focused more on managing the cost of care and less on managing healthcare. Minimal attention was given to the preferences and expectations of the insured as well as those of service providers. This led to the situation that although managed care was considered to be useful in theory, there are considerable problems in its implementation. There is hardly clarity on the instruments and organisational forms that belong to managed care while fully accepted methods, such as working according to guidelines or disease management, are not seen as connected to managed care. In general, the following four main objectives and expectations are associated with managed care will be discussed: (a) the cost of managed care, (b) quality effects of managed care, (c) access effects of managed care, (d) acceptance of managed care.

Literature

  1. Baumberger, J., & Künzi, M. (2010). 20 Jahre HMO und Managed Care in der Schweiz: Managed Care – Erfolgsgeschichte ohne Wirkung? clinicum (pp. 1–10).Google Scholar
  2. BDI [Berufsverband Deutscher Internisten e.V.]. (2012). Forum managed care: Wahl-GAU im Aargau. Last accessed March 13, 2018, from https://www.bdi.de/aktuell/nachrichten/ansicht/article/forum-managedcare-wahl-gau-im-aargau/
  3. Berchtold, P., & Hess, K. (2006). Evidenz für Managed Care – Europäische Literaturanalyse unter besonderer Berücksichtigung der Schweiz: Wirkung von Versorgungssteuerung auf Qualität und Kosteneffektivität (Arbeitsdokument 16). Neuchâtel: Schweizerisches Gesundheitsobservatorium.Google Scholar
  4. Born, P. H., & Simon, C. J. (2001). Patients and profits: The relationship between HMO financial performance and quality of care. Health Affairs, 20(2), 167–174.CrossRefGoogle Scholar
  5. Buchanan, A. (1998). Justice, but not unjustly. Journal of Health Politics, Policy and Law, 23, 132–143.CrossRefGoogle Scholar
  6. Bundorf, M. K., Schulman, K. A., Stafford, J. A., et al. (2004). Impact of managed care on the treatment, costs, and outcomes of fee-for-service Medicare patients with acute myocardial infarction. Health Services Research, 39(1), 131–152.CrossRefGoogle Scholar
  7. Dudley, R. A., & Luft, H. S. (2001). Managed care in transition. The New England Journal of Medicine, 344(14), 1087–1092.CrossRefGoogle Scholar
  8. Dudley, R. A., Miller, R. H., Korebrot, T. Y., et al. (1998). The impact of financial incentives on quality of health care. The Milbank Quarterly, 76, 649–688.CrossRefGoogle Scholar
  9. MAHP [Market Aceess & Health Policy]. (2012). Managed-Care-Gesetzesvorlage in der Schweiz. Last accessed March 13, 2018, from http://www.healthpolicy-online.de/news/schweiz-beschliesst-managed-care-gesetz-zukuenftig- sollen-60-prozent-der-schweizer-in-der-integrierten-versorgung-eingeschrieben-sein
  10. Meyer, P. C., & Denz, M. D. (2000). Sozialer Wandel der Arztrolle und der Ärzteschaft durch Managed Care in der Schweiz. Das Gesundheitswesen, 62, 138–142.CrossRefGoogle Scholar
  11. Robinson, J. C. (2001). The end of managed care. JAMA: The Journal of the American Medical Association, 285(20), 2622–2628.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Volker Eric Amelung
    • 1
    • 2
  1. 1.Institute for Epidemiology, Social Medicine and Health Systems ResearchHannover Medical SchoolHannoverGermany
  2. 2.Institute of Health Sciences Research INAV GmbHBerlinGermany

Personalised recommendations